Remedy Robotics
PrivateLast Round
Series B
Oct 10, 2025
Total Funding Raised
$35M
Company Overview
Remedy Robotics is a medical technology company developing a remotely-operated endovascular robotic system for cardiovascular care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedy Robotics Comparables
Compare Remedy Robotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moon Surgical | 83% | |
| XCath | 80% | |
| Vicarious Surgical Inc. | 80% | |
Remedy Robotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 10, 2025 |
Key People
Founding team and executive leadership
Remedy Robotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Build Collective | Series A, Series B |
| KdT Ventures | Series A, Series B |
| Blackbird Ventures | Series A, Series B |
| DCVC (Data Collective) | Seed, Series A, Series B |
Remedy Robotics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedy Robotics's valuation, stock price, and market status.